Scimago Lab
powered by Scopus
call: +1.631.629.4328
Mon-Fri 10 am - 2 pm EST
CURRENT VOLUME: 21, 2020
Recent Articles (35) in last 30 days
Unknown ethiology (1)
Unusual clinical course (8)
Rare disease (9)
Rare co-existance of disease or pathology (7)
Diagnosis (15)
Challenging differential diagnosis (12)
Mistake in diagnosis (3)
Unusual or unexpected effect of treatment (5)
Unusual setting of medical care (2)
Management of emergency care (4)
Complications and accidents (5)
Diagnostic / therapeutic accidents (5)
Drug reactions (3)
Unexpected drug reaction (3)
Educational Purpose (only if useful for a systematic review or synthesis) (6)
Clinical situation which can not be reproduced for ethical reasons (2)
Archival Case Reports
Diseases (1935)
Unknown ethiology (69)
Unusual clinical course (654)
Rare disease (908)
Congenital defects / diseases (94)
Rare co-existance of disease or pathology (210)
Diagnosis (1180)
Challenging differential diagnosis (1036)
Mistake in diagnosis (144)
Treatment (984)
Unusual or unexpected effect of treatment (401)
Unusual setting of medical care (296)
Management of emergency care (287)
Complications and accidents (490)
Diagnostic / therapeutic accidents (420)
Patient complains / malpractice (70)
Drug reactions (270)
Unexpected drug reaction (158)
Adverse events of drug therapy (112)
Educational Purpose (only if useful for a systematic review or synthesis) (840)
Clinical situation which can not be reproduced for ethical reasons (61)
Archival Volumes
Volume 8, 2007 [CaseRepClinPractRev]
Vol. 4 (4) 2003
Indexation Info
Processing fee online payment
Get your full text copy in PDF
Oxacillin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
Alexis Sharpe, Bashar M. Mourad, Chase J. Hardwick, Theresa Reilly, Ezra Dweck, Eric Bondarsky
(Department of Pulmonary and Critical Care, NYU Langone, New York City, NY, USA)
Am J Case Rep 2019; 20:345-348
DOI: 10.12659/AJCR.913748
BACKGROUND: Drug reaction with eosinophilia and systemic symptoms (DRESS) is an idiosyncratic life-threatening reaction comprised of fevers, rash, and leukocytosis with eosinophilia. Though characteristically associated with leukocytosis, there are rare case reports of DRESS-induced agranulocytosis. DRESS is most frequently caused by antiepileptic medications; however, it has very rarely been reported in relation to oxacillin. We describe a case of oxacillin-induced DRESS associated with agranulocytosis.
CASE REPORT: A 52-year-old male was admitted for an epidural abscess secondary to oxacillin-sensitive Staphylococcus aureus, for which an extended course of oxacillin and rifampin was initiated. On day 22 of therapy, the patient developed a fever of 38.7°C (101.6°F) with rigors. His complete blood cell count revealed new leukopenia (1.8×10³/uL) with 16% eosinophils and 3% atypical lymphocytes. Antibiotics were transitioned from oxacillin and rifampin to vancomycin, cefepime, and rifampin for presumed sepsis of unclear etiology. On day 23, he was noted to have a pruritic erythematous blanching papular rash on his chest, trunk, neck, and left upper extremity. Infectious workup was unrevealing, and his fever curve up-trended to 39.3°C (102.7°F) with no clinical improvement on broad-spectrum antimicrobials, suggestive of a non-infectious etiology of his rash and fevers. His rash evolved into confluent red patches, and eosinophilia rose to 21%, which was concerning for a drug reaction. His RegiSCAR score was calculated to be 6, consistent with definite DRESS. Leukopenia resolved (6.3×10³/uL) 4 days after discontinuing oxacillin. His epidural abscess was ultimately treated with daptomycin, and DRESS was managed supportively with antihistamines and triamcinolone cream.
CONCLUSIONS: We highlight this case because of the rarity of DRESS with agranulocytosis related to oxacillin. Beta-lactam antibiotics are widely used, and while DRESS is an uncommon condition, clinicians should consider this diagnosis when managing patients with fevers, leukopenia, and rash.
This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
Copyright by International Scientific Information 2002 - 2020